Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Studying the progress of COVID-19 outbreak in India using SIRD model

Saptarshi Chatterjee, Apurba Sarkar, Swarnajit Chatterjee, Mintu Karmakar, Raja Paul
doi: https://doi.org/10.1101/2020.05.11.20098681
Saptarshi Chatterjee
1Indian Association for the Cultivation of Science, Kolkata-700032, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Apurba Sarkar
1Indian Association for the Cultivation of Science, Kolkata-700032, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Swarnajit Chatterjee
1Indian Association for the Cultivation of Science, Kolkata-700032, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mintu Karmakar
1Indian Association for the Cultivation of Science, Kolkata-700032, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raja Paul
1Indian Association for the Cultivation of Science, Kolkata-700032, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: raja.paul@iacs.res.in
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We explore a standard epidemiological model, known as the SIRD model, to study the COVID-19 infection in India, and a few other countries around the world. We use (a) the stable cumulative infection of various countries and (b) the number of infection versus the tests carried out to evaluate the model. The time-dependent infection rate is set in the model to obtain the best fit with the available data. The model is simulated aiming to project the probable features of the infection in India, various Indian states, and other countries. India imposed an early lockdown to contain the infection that can be treated by its healthcare system. We find that with the current infection rate and containment measures, the total active infection in India would be maximum at the end of June or beginning of July 2020. With proper containment measures in the infected zones and social distancing, the infection is expected to fall considerably from August. If the containment measures are relaxed before the arrival of the peak infection, more people from the susceptible population will fall sick as the infection is expected to see a three-fold rise at the peak. If the relaxation is given a month after the peak infection, a second peak with a moderate infection will follow. However, a gradual relaxation of the lockdown started well ahead of the peak infection, leads to a nearly two-fold increase of the peak infection with no second peak. The model is further extended to incorporate the infection arising from the population showing no symptoms. The preliminary finding suggests that random testing needs to be carried out within the asymptomatic population to contain the spread of the disease. Our model provides a semi-quantitative overview of the progression of COVID-19 in India, with model projections reasonably replicating the current progress. The projection of the model is highly sensitive to the choice of the parameters and the available data. Besides, since the pandemic is an ongoing dynamic phenomenon, the reported results are subjected to regular updates in consonance with the acquired real data.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Saptarshi Chatterjee and Apurba Sarkar were supported by a fellowship from the University Grants Commission (UGC), India. Mintu Karmakar was supported by a fellowship from CSIR, India. Swarnajit Chatterjee thanks Indian Association for the Cultivation of Science, Kolkata for financial support. Raja Paul thanks IACS for support and Grant No. EMR/2017/001346 of SERB, DST, India for the computational facility.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The working institute Indian Association for the Cultivation of Science, Kolkata, India has approved the research.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The real data for analysis in India's context is collected from the repository with an interactive interface hosted at https://www.covid19india.org. The data for other countries are taken from the repository with an interactive interface hosted at https://www.worldometers.info/coronavirus.

https://www.covid19india.org

https://www.worldometers.info/coronavirus

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 30, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Studying the progress of COVID-19 outbreak in India using SIRD model
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Studying the progress of COVID-19 outbreak in India using SIRD model
Saptarshi Chatterjee, Apurba Sarkar, Swarnajit Chatterjee, Mintu Karmakar, Raja Paul
medRxiv 2020.05.11.20098681; doi: https://doi.org/10.1101/2020.05.11.20098681
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Studying the progress of COVID-19 outbreak in India using SIRD model
Saptarshi Chatterjee, Apurba Sarkar, Swarnajit Chatterjee, Mintu Karmakar, Raja Paul
medRxiv 2020.05.11.20098681; doi: https://doi.org/10.1101/2020.05.11.20098681

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8789)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1863)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10565)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1756)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (265)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1845)
  • Public and Global Health (3986)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)